Noteworthy

Nov 12, 2017
Prognos CEO Sundeep Bhan talks about how the company’s unique offering will reach beyond life sciences as the long-promised benefits of AI become reality.
Nov 07, 2017
While most pharma companies are in partial production using generators, few are operating at 100% capacity, writes Jill Wechsler.
Nov 06, 2017
Pharmaceutical Executive
Can health stakeholders be friends without being captives? Reflector reports.
Oct 31, 2017
Pharmaceutical Executive
Pharm Exec’s 10th annual list of rising leaders highlights 11 pharma managers who are poised to help chart the industry’s path forward.
Oct 17, 2017
Pharmaceutical Executive
Today’s model requires a fourth partner—the systems integrator, writes Adam Nelson.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
Oct 09, 2017
Pharmaceutical Executive
What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
Oct 06, 2017
TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
native1_300x100
lorem ipsum